NOTCH1 and B-cell chronic lymphocytic leukemia: Recently, the association of NOTCH1 mutation and low BAX/BCL-2 ratio showed synergistic prognostic properties in patients treated with Ibrutinib, identifying a CLL subset with reduced OS and PFS (88).